The DES (diethylstilbestrol) years: Bridging the past into the future

Martin A. Martino, Nicole S. Nevadunsky, Thomas J. Magliaro, Michael I. Goldberg

Research output: Contribution to journalArticle

14 Scopus citations

Abstract

Between the years 1941-1971, it is estimated that between 5 million and 10 million pregnancies were exposed to diethylstilbestrol (DES). The adverse consequences of this exposure in utero had been reported as early as 1949. However, it was not until the development of a rare vaginal cancer known as clear-cell adenocarcinoma in 1971 that the implications with regard to teratogenicity of this steroid were identified. The use of anecdotal reports to develop preventive treatments cautions physicians regarding the consequences that may result when anecdotal reports are relied on to determine medical management rather than evidence-based research. This article will review the history and pathology of DES and alert the primary care physician to the misfortunes of our past and the implications they may have in the future. With the increased prevalence of alternative treatments and homeopathic remedies, the contemporary physician must be mindful of the importance of evidence-based medicine when prescribing therapeutics. Finally, this article will discuss the importance of evidence-based medicine and remind us to learn from our past experiences when we introduce new treatments in the future.

Original languageEnglish (US)
Pages (from-to)7-12
Number of pages6
JournalPrimary Care Update for Ob/Gyns
Volume9
Issue number1
DOIs
StatePublished - 2002

ASJC Scopus subject areas

  • Nursing(all)
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'The DES (diethylstilbestrol) years: Bridging the past into the future'. Together they form a unique fingerprint.

  • Cite this